Idiopathic thrombotic thrombocytopenic purpura (TTP)is
INTRODUCTION
Idiopathic thrombotic thrombocytopenic purpura (TTP) and sporadic hemolytic uremic syndrome (HUS) are thrombotic microangiopathies of uncertain etiology. TTP is clinically defined by thrombocytopenia, microangiopathic anemia, renal dysfunction, mental status changes, and fever. Sporadic HUS is a pathologically identical condition that manifests by a predominance of renal changes. The incidence of TTP/sporadic HUS in the general population is 1 in 10 5 to 10 6 (Kwaan, 1987) . Interest in these conditions has grown because of the recent findings of a marked increase in the incidence of TTP associated with HIV infection (4 log-fold) (Bell et al., 1997) and with the use of the anti-platelet, anti-ADP receptor drug ticlopidine (2.5 log-fold) as well as with clopidogrel (Bennett et al., 1998 (Bennett et al., , 2000 Mauro et al., manuscript in preparation) .
In previous studies (Dang et al., 1999; Mitra et al., 1997 Mitra et al., , 1998 Laurence and Mitra, 1997; Laurence et al., 1996) we reported that TTP/sporadic HUS plasmas induced apoptosis in primary human microvascular endothelial cells (MVEC) of renal, cerebral, tonsillar, hepatic, cardiac, and dermal origin, but strikingly, not lung MVEC nor EC of large vessel origin. In vitro changes reflect the distribution of apoptotic lesions in vivo in TTP (Dang et al., 1999) , including the consistent sparing of the pulmonary vasculature. In vitro and in vivo upregulation of the apoptosis-associated receptor Fas, and of apoptosis-effector proteases such as caspases 1 and 3 in vitro following exposure of susceptible EC to TTP plasma, has been demonstrated (Dang et al., 1999; Mitra et al., 1998) . Anti-Fas reagents have little effect in modulating apoptosis in this system (Laurence et al., 1996) but specific caspase inhibitors block cell death, as does overexpression of Bcl-2 homologues A1 and Bcl-xL (Mitra et al., 1998) .
In addition to traditional apoptotic pathways, extracellular matrix (ECM) proteins such as fibronectin, ECM-associated adhesion molecules, and metalloproteinases (MMP) may play a role in EC injury through a process known as anoikis, in which certain cells of endothelial and epithelial lineage, upon losing their anchorage to the ECM, undergo apoptosis. Anoikis may explain the link between TTP and HIV or ticlopidine as both HIV-and ticlopidine-associated TTP are associated with disruption of ECM proteins and/or adhesion molecules required to maintain EC survival (Meredith et al., 1993; Scatena et al., 1998; Richards et al., 1996) .
We employed oligonucleotide genechip technology to explore these and other possible mechanisms for the resistance of lung MVEC to apoptosis in TTP as well as bases for the differences between MVEC of pulmonary and dermal origin. We examined the pattern of gene expression in primary human lung MVEC with and without exposure to TTP plasma. Skin MVECs, which are always involved by TTP in vivo, served as controls. A Hu6800 Genechip (Affymetrix), containing over 6800 human genes, was used. The direction of changes in expression of genes linked to both anti-and pro-apoptotic pathways 24 h after TTP plasma exposure in lung EC correlated with preexisting baseline levels of expression of these genes in skin EC. Specific genes of potential pathogenic importance that we identified include the apoptosis-associated death ligand TRAIL (tumor necrosis factor related apoptosis inducing ligand), caspases 1 and 6, and metalloproteinase-9 (MMP-9). In addition, lung MVEC may better resist the TTP stimulus by baseline elevated expression of prosurvival genes such as a soluble decoy receptor for TRAIL, osteoprotegerin (OPG) (Emery et al., 1998) and vascular endothelial growth factors, VEGF/VPF and VEGF-C/VPR, and their receptors, VEGFR-2/KDR and VEGFR-3/flt4 (Zachary, 1998; Cao et al., 1998) , as well as by TTP plasma-mediated induction of Bcl-xL. Identification of lineage-specific survival pathways in MVEC may help to define new modalities to treat TTP, as well as to induce apoptosis in MVEC of selected lineage in the treatment of disorders dependent on neovascularization.
MATERIALS AND METHODS

Patients
TTP was diagnosed according to the following criteria: unexplained oral temperature Ͼ38°; neurological dysfunction (any abnormality on general medical neuropsychiatric exam); renal dysfunction, serum creatinine Ͼ1.2 mg/dl or Ͼ150% of baseline; and thrombocytopenia, platelet Ͻ150,000/mm 3 . Plasma derived from the patient used in this study, a 47-year-old Caucasian woman with relapsing TTP, was selected for demonstrating a typical pattern of tissue-specific apoptosis both in vitro (primary MVEC systems) and in vivo (Dang et al., 1999) .
Cell Culture and RNA Isolation
Two types of primary MVECs were used: human skin and lung MVEC (Clonetics, San Diego, CA). These cells were CD34 positive on first isolation, indicating their origin as microvascular endothelial cells as opposed to being of large vessel origin, such as the HUVEC. The cells were grown in a modified MCDB 131 medium containing recombinant human epidermal growth factor (10 ng/ml), heparin (10 g/ml) (M199 medium), 18% fetal bovine serum, and 2% pooled human serum (HS) at final passage 6 in T75 flasks coated with 0.2% gelatin. All EC were subjected to M199 medium without HS but with 15% FCS for 18 h and then to either 1% control human plasma (both skin MVEC and lung MVEC) or plasma from the TTP patient (lung MVEC) for 24 h. Flow cytometric analysis of DNA histograms from RNase-treated, propidium-iodide-stained cells revealed a hypodiploid apoptotic Ao peak of 0% in lung TTP cells, but 35% in skin TTP. The latter was associated with Ͼ90% apoptotic cells as revealed by DAPI (4Ј-6-diamidino-2-phenylindole) staining and direct visualization. After treatment, the cells were collected with 0.2% trypsin-EDTA and the total RNA was extracted (TriZol, Gibco/BRL).
Preparation of cRNA
Affymetrix (Affymetrix, Santa Clara, CA) provided the methods for preparation of cRNA, hybridization, and scanning of the Hu6800 Genechip arrays and, they were carried out as described previously (Der et al., 1998) . Biotin-labeled cRNA from three cell sources (skin MVEC, lung MVEC, lung MVEC exposed to TTP plasma for 24 h) were synthesized. Poly (A)ϩ RNA isolation and cDNA synthesis were carried out as previously described (Der et al., 1998) . The cRNA was labeled and synthesized from cDNA by an in vitro transcription system (T7 MegaScript System, Ambion) using biotin-11-CTP and biotin-16-UTP (Enzo). The purified cRNA (Chroma Spin-100, Clontech) was fragmented with a mild alkaline buffer (40 mM Trisacetate, pH 8.1/100 mM potasssium acetate/30 mM magnesium acetate) and heat (94°ϫ 25 min). A master hybridization mix containing 0.1 mg/ml of herring sperm DNA (Sigma)/1 M NaCl/10 mM Tris, pH 7.6/ 0.005% Triton X-100, and a mixture of four control cRNAs from bacteriophage genes were added (BioB, BioC, and CRE, at 1.5, 5, 25, and 100 pM) for comparing the uniformity of the hybridization between the gene chips and for standardization of signal. A biotinylated oligonucleotide, B2, facilitated the orientation and mapping of the probe sets.
Oligonucleotide Array Hybridization and Scanning
The Hu6800 Genechip is represented by four chips (A-D), each containing sequences from about 1700 different genes. These include some "KIAA" genes of unknown function derived from cDNA clones of human cell line KG-1 (Nagase et al., 1995a (Nagase et al., ,b, 1996 . Each gene is derived from 20 25-mer oligonucleotide probes representing a region toward the 3Ј end area of the gene. Each oligonucleotide additionally has a probe pair containing a homomeric mismatch in the center of the sequence (Lipshutz et al., 1999) . Differential hybridization signals between probe pairs confer a higher signal specificity and greater accuracy in gene identification.
The cRNA was heated (94°ϫ 5 min), equilibrated (40°ϫ 5 min), and clarified by centrifugation (14,000g) for 5 min. The resultant sample was hybridized to Hu6800 Genechip arrays at 40°for 16 h in a rotisserie oven rotated at 60 rpm. The chips were washed (6ϫ SSPE and 0.5ϫ SSPE), labeled with strepavidin-phycoerythrin (SAPE) (Molecular Probes), and then treated with biotinylated anti-strepavidin antibody, followed by SAPE to amplify the signal. This resulted in an overall sixfold increase in signal and a higher sensitivity for gene detection in our samples. The fluorescence intensity signals of the genechips were read by a confocal microscope scanner with a 560-nm longpass filter (Molecular Dynamics, Affymetrix).
Data Analysis
Data analysis was performed using Genechip 3.1 software. First, a profile of absolute intensities was generated for each sample to assess both the uniformity of hybridization using the bacteriophage controls described above and the expression of actin and GAPDH among the three EC samples. Based on this normalization, expression of known apoptosis-associated genes was compared directly. Second, a comparison analysis algorithm, Genechip 3.1, was utilized. Briefly, this involved: (i) normalization of genechip signal intensities of all probe sets from each of the three samples-a process comparable to normalizing the amount of cRNA by integrating the sum of all the fluorescence intensities; (ii) a systematic subtraction of background, with algorithmic cutoffs for "positive" and "negative" signal strength as defined by subtractive (average difference) and divisional changes (fold changes) in probe pair signals; and (iii) use of a sort score, a multiplier value based on both fold changes and differences in signal intensity between samples from a common set of probe pairs.
These comparative analyses were performed for both single-and double-stained data sets with probe mask software which diminished intronic signals (affecting about 20% of the genes represented in the array) and enhanced the specificity of the data. This process involved using only the gene probe sets with Ͼ10 probe pairs matching unambiguously. We used a sort score magnitude cutoff of 0.5, which is a highly stringent value (Der et al., 1998) . We used a Ͼ2-fold change in cRNA expression as a significant difference consistent with the work of others (Der et al., 1998; Wang et al., 1999) .
RESULTS
Integrity of the Generated Data
To assess the purity of the starting material, endothelial cell integrity was checked by noting the presence or absence of various specific EC, mesothelial, and smooth muscle cell marker genes. As shown in Table 1 , desmin, an intermediate filament protein found in smooth muscle cells, pericytes, and mesothelial cells, was absent, as was vimentin, a marker for epithelial cells (Hewett and Murray, 1993; Cines et al., 1998) . In contrast, EC markers such as von Willebrand factor and platelet/endothelial cell adhesion molecule-1 (PECAM-1) were present in all samples (Table   1 ) although at differing amounts in the two EC lineages. Thrombomodulin was detectable in the skin but not in the lung MVEC samples (see Discussion for a possible interpretation).
Approximately 2000 genes were expressed in each of our cell sources with a fluorescence intensity range span of 2 orders of magnitude. To assess the level of cRNA between samples, the absolute intensities of two housekeeping genes, actin and GAPDH, were compared. As expected of genes generated from a reverse transcription, the 3Ј end of the genes was amplified more abundantly than the 5Ј end of the genes (range 56 to 89%). The 3Ј end signal of the genes was uniform among samples; the maximal differences for actin was 37 and 11% for GAPDH among the three samples, and 11 and 6%, respectively, between the pulmonary cell samples. In addition, one of the genechip hybridizations was repeated with no detectable differences.
Data Analysis
Given this small variance in signals of the 3Ј end of GAPDH and actin between samples and uniformity of hybridization as assessed by control bacterial genes, a direct comparison of absolute fluorescence intensities of other genes was carried out. This enabled a direct comparison of data for genes with potential functionality in the pathogenesis of TTP that were not selected by the stringent software comparative analysis. Categories of genes potentially related to cell survival/ apoptosis were compared between the lung MVECs with and without TTP plasma exposure. Figures 1a-e represent a selected group of these genes. Previous work with semiquantitative RT-PCR analyses had demonstrated that TTP plasma derived from many patients caused increased expression of caspase 1 and that addition of a specific tetrapeptide inhibitor of this enzyme abrogated the apoptotic effect of TTP plasma on susceptible EC (Mitra et al., 1998) . Figure 1a shows that gene expression of caspases 1 and 6 in lung EC was 2-fold increased by TTP plasma. However, caspases 3 and 10 expression was decreased about 1.5-fold and 6-fold, respectively, by TTP plasma. Since these enzymes exist as pro-enzymes, these assays may not reflect functional enzyme activity. Figure 1b represents levels of expression of some of the Bcl-2 family of genes-both pro-(Bax) and antiapoptotic (Bcl-2 and Bcl-xl)-as well as other genes involved in regulating endothelial cell survival such as TGF␤ and inhibitor of apoptosis B (IAP-B)). As predicted by previous work, the expression of the anti-apoptotic genes, Bcl-2 and Bcl-xl , was low at baseline. TTP plasma exposure, however, increased levels significantly. IAP-B gene was expressed at higher levels in lung than in skin MVEC (not shown) but TTP plasma caused a threefold decrease in expression (Fig. 1b) . Expression of the pro-apoptotic Bax gene was markedly increased by TTP plasma. Transforming growth factor-beta1 (TGF␤-1), which can also contribute to the overall cell survival (Rieck et al., 1995) , was increased twofold by TTP plasma. Figure 1c shows the effect of TTP plasma on the gene expressions of molecules involved in the initiation of apoptosis. Consistent with our previous RT-PCR results , Fas was increased twofold by TTP plasma. Among some of the other initiators of apoptosis, tumor necrosis factor ␣-converting enzyme (twofold), caspase and RIP adapter with death domain (twofold), and death domain receptor 3 (fourfold) were found to be induced by TTP, while TNF receptor associated factor 6 (twofold) and TRAIL (from present to absent) were reduced. OPG gene expression, a soluble decoy receptor for TRAIL with a high affinity (3.0 nM), was unchanged.
To assess the role of ECM for EC survival, expression of ECM genes and genes known to be involved in ECM-cell interactions was examined (Fig. 1d) . Fibronectin gene expression was increased threefold. Expression of integrin genes was low at baseline and did not change significantly (data not shown). Metalloprotease-1 (threefold), MMP-9 (from none to present), and metalloprotease/disintegrin/cysteinerich protein precursor (MDC9) (twofold) as well as tissue inhibitor of metalloprotease-1 (TIMP-1) (twofold) gene expressions were induced by TTP plasma. Thus, TTP plasma caused a general modulation of genes towards loss of EC-ECM anchorage while also causing increased fibronectin and TIMP-1 in lung MVECs.
To assess the role of angiogenesis, expression of selected pro-and anti-angiogenic genes was examined (Fig. 1e) . Inducible nitric oxide synthase (iNOS) was increased 2-fold. The precursor to endostatin, collagen XVIII, was unchanged (not shown). Among the proangiogenic/prosurvival genes, VEGF/VPF (3-fold), VEGF-C/ VPR (3-fold), and the receptors, VEGFR-1/ Flt-1 (3-fold) and VEGFR-3/ Flt-4 (15-fold), as well as annexin II (1.5 fold), were reduced while VEGFR-2/ KDR and Cox-2 remained constant. Notable among some physiologically important pro-angiogenic genes, basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) and its receptor were not detectable at baseline. Heparin-binding EGF-like growth factor gene was suppressed while VEGFR kinases 1 and 2 (VRK1, VRK2) were both increased 2-fold. (not shown). VEGF is known to inhibit the apoptosis of human MVEC via opposing effects on the MAPK/ERK and SAPK/JNK signaling pathway (Gupta et al., 1999) . We found that the expression of JNK1 increases while that of ERK remains stable with TTP treatment (data not shown). By Western blot analysis, our laboratory has demonstrated the same changes (Mauro et al., manuscript in preparation) .
Relationship between TTP Plasma Modulation of Lung MVEC and Baseline Gene Expression in Lung and Skin MVEC
To determine possible pathways for the intrinsic ability of lung MVEC to resist TTP-induced apoptosis, we examined whether there was a correlation between baseline levels of gene transcripts in skin and lung MVECs and an induction/reduction of these same genes following TTP plasma treatment of the latter. The software analysis compared the levels of transcripts present in lung and skin MVEC versus the effect of TTP plasma on the same gene expression in lung MVEC (Fig. 2) . This procedure identified a total of 157 differentially expressed (by at least 2-fold) and 40 invariant genes following TTP stimulation of the lung MVEC. These were sorted into three categories: (I) present at higher baseline expression in skin than in lung MVEC; (2) lower baseline expression in skin than in lung MVEC; and (3) no difference at baseline. All of the lung MVEC genes that were unchanged following TTP plasma exposure were expressed at similar amounts in lung and skin MVEC. Only 44% of the genes that were altered by TTP plasma exposure had similar baseline expressions in the skin and lung MVEC. One-quarter of the 157 genes modulated by TTP are linked to cell survival/apoptosis.
Although not selected by the software analysis, a selection of genes from Fig. 1 was examined to assess whether genes associated with apoptotic pathways expressed by lung MVEC are also altered by TTP plasma to assume expression patterns characteristic of dermal MVEC at baseline. TTP plasma did alter expression in lung MVEC to resemble dermal MVEC with respect to some pro-and anti-apoptotic gene expression which include Fas, Bax, MMP-9, iNOS, and caspase 1 (data not shown). Notable exceptions, however, are KDR and OPG, for which expression remained invariant after TTP plasma stimulation and higher than in skin MVEC, and TRAIL (Degli-Esposti, 1999), for which expression decreased in lung MVEC exposed to TTP plasma, while the baseline skin expression was higher than in lung MVEC.
DISCUSSION
A variety of studies have begun to uncover phenotypic and functional differences among microvascular EC of varying lineage. In one approach to exploring the nature of these differences and their biologic consequences, we have utilized oligonucleotide chip technology to examine a human disease associated with apoptosis of MVEC of specific tissue types in vitro and in vivo. We hypothesized that tissue-specific differences in baseline expression of death and decoy receptors account for differential susceptibility of MVEC to TTP plasma-associated factors. Previous work has shown that maneuvers that inhibit common downstream events in various apoptotic pathways, including overexpression of protective Bcl-2 family members (A1 and Bcl-xl) and inhibition of caspases 1 and 3, protect against TTP plasma-induced apoptosis in susceptible MVEC (Mitra et al., 1998) . Although Fas is overexpressed by MVEC in TTP in vivo and following TTP plasma exposure in vitro, it appears to serve merely as an indicator of activated EC. Antibodies against Fas do not reverse the TTP plasma effect (Laurence et al., 1996) , suggesting involvement of alternative apoptotic pathways. The present work focused on the identification of potential apoptotic mechanisms by analyzing changes in gene expression induced by TTP plasma in our model resistant cells, lung MVEC. In addition, baseline levels of expression of these and other genes were compared to those of TTP-susceptible skin MVEC. Figure 3 summarizes the balance of pro-and antiapoptotic genes derived from our experimental data (Figs. 1a-e) that may play a role in TTP-induced apoptosis. TTP plasma caused a modulation of both proand anti-apoptotic genes in TTP-resistant lung MVEC. Decreased expression of TRAIL after TTP suggests a potential mechanism that may be crucial in conferring a resistant phenotype to lung MVEC. In contrast to lung MVEC, TRAIL expression is high in skin cells and increased further after exposure to TTP plasma (by RT-PCR, data not shown). In addition, our studies identified baseline differences in prosurvival genes between the two EC suggesting a differential level of maintenance of survival signals. For example, OPG and VEGFR-2/KDR gene expression was higher in the lung than in skin cells and TTP stimulation did not alter the level of expression significantly in lung cells (Fig. 3) .
Our postulate of a role for angiogenic prosurvival signals in resistance of lung MVEC to apoptosis induction is also supported by expression patterns of other genes which are linked to these pathways. For example, Cox-2 gene is expressed at higher levels in lung than in skin MVEC (not shown) and is unchanged by TTP plasma exposure of lung MVEC. Cox-2 can be induced by a variety of stimuli to generate eicosanoids (particularly PGE2), which themselves are inducers of basic regulators of angiogenesis such as VEGF, bFGF, TGF␤, PDGF, and endothelin-1. Cox-2 also induces iNOS (Chiarugi et al., 1998) . INOS was increased by TTP plasma in lung MVEC (Fig. 1e ) and can be further increased by VEGF via VEGFR-2/ KDR (Chiarugi et al., 1998) and thus may serve to amplify the prosurvival signal. Generation of low levels of nitric oxide helps to preserve the integrity of the endothelium by preventing EC apoptosis in response to cytotoxic cytokines such as TNF␣ (Kroll and Waltenberger, 1998) . NO mediates this effect via two mechanisms: inhibition of NF-B activation and suppression of caspases 1 and 3 (Kroll and Waltenberger, 1998) . NO also modifies ECM composition by regulating the activation of metalloproteinases (Peng et al., 1995) and thus may also be involved in inhibiting anoikis. The significance of this observation is supported by the fact that administration of l-arginine, a precursor molecule to NO, results in reduced relapse rates in recalcitrant TTP cases (Herlitz et al., 1997) . The importance of the involvement of proteases may be relevant to the findings of Warwicker et al. (1999) , who demonstrated that a decrease in protein levels of a specific metalloprotease correlate with increased circulative von Willebrand factor multimeric forms in TTP although this may primarily be secondary to the presence of antibody inhibitors (Warwicker et al., 1999; Tsai et al., 2000) . Genes which are either induced from or reduced to nondetectable levels by TTP plasma may be a particularly fruitful area for future investigation. These include TRAIL, caspase 10, and Bcl-xl and MMP-9 (Figs.  1 and 3) . MMP-9 stands out as a singular pro-apoptotic signal and its expression is consistent with upregulation of metalloprotease in TTP plasma (Furlan, 1999) . In addition, a large decrease (15-fold) in the gene expression of VEGFR-3 with an accompanying decrease in the expression of VEGF-C (Cao et al., 1998) in lung EC after TTP plasma exposure suggests that the loss of these survival signals may be important in the pathogenesis of TTP. Thus, three avenues of further experimental investigation are suggested by this array analysis: the role of TRAIL and its receptors (Sheridan et al., 1997; MacFarlane et al., 1997; Pan et al., 1997) in apoptosis caused by TTP; the involvement of MMPs and their inhibitors in ECM-related anoikis; and the role of angiogenic receptor VEGFR-2/KDR and VEGFR-3/flt-4 in maintaining survival specifi-
FIG. 3.
Summary of pro-and anti-apoptotic gene modulation by TTP. The list of genes in the central balance contains TTP-modulated genes in lung MVECs. The side balances illustrate anti-apoptotic genes which are more abundant in lung than in skin EC (lung Ͼ skin) and pro-apoptotic genes which are more more abundant in skin than in lung EC (skin Ͼ lung).
cally of lung MVECs. As in excess of 25% of MVEC in the human body is of pulmonary origin (Hewett and Murray, 1993) , gaining an understanding of the molecular basis for diversity among microvascular EC in general, as well as protective mechanisms for lung MVEC in particular, is of special importance. Unraveling the overall importance of various cellular pathways that contribute to the differential EC susceptibity to apoptosis in the pathogenesis of TTP may be valuable in developing new specific therapeutic modalities (Wu et al., 1997; Boehm et al., 1997) . For example, identification of specific MVEC apoptosis-inducing factors may have possible therapeutic value in diseases that require a control of blood supply to specific organ systems at the microvascular level.
The new technology that we have employed offers a synthetic view of how the different cellular pathways are involved. However, as a note of caution, the level of message and protein expression may not always correlate. For example, thrombomodulin was detectable in the skin MVEC but not in the two lung MVEC samples. This molecule has been implicated in the pathogenesis of TTP and was shown by immunohistochemistry to be present in the lung microvasculature (Maruyama et al., 1985) . This discrepancy between the protein expression and message level is difficult to interpret because we are looking at a single time point.
